Brooks Laboratories opened higher at ₹66.00, compared with its previous close of ₹65.54. During today's session, the stock has traded between ₹63.30 and ₹69.90, with an average traded price of ₹66.44. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Brooks Laboratories is now worth
₹ 4,883.00
resulting in a loss of
₹ 5,117.00 (51.17%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.78 (-1.19%)
Day High
₹69.90
Day Low
₹63.30
Day Open
₹66.00
Prev Close
₹65.54
Volume
2,23,762
Value Traded
₹1.49 Cr
1W Return
19.40%
1M Return
-1.42%
3M Return
-8.06%
6M Return
-10.30%
1Y Return
-48.11%
Market Cap (₹ Cr.)
191
PE Ratio
14.60
PB Ratio
1.58
Dividend Yield
-
ROE
20.04%
ROCE
20.12%
Book Value (₹)
41.64
Face Value (₹)
10.00
EPS (TTM)
-0.61
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
19.40%
6 Week
-
1 Month
-1.42%
3 Month
-8.06%
9 Month
-9.53%
Brooks Laboratories accepts resignation of company secretary
Brooks Laboratories accepts resignation of Company Secretary Ms. Krutika Rane. Effective date for cessation of duties is October 9, 2026. Reason cited is pursuit of alternate career opportunity outside organization. Disclosure made under Regulation 30 of SEBI Listing Regulations on September 16, 2026.
27 days agoBrooks Laboratories AGM resolutions pass with 99.99% shareholder support
Brooks Laboratories published final e-voting results for its 24th AGM held on September 3, 2026. All six ordinary resolutions passed with support exceeding 99.99% from participating shareholders. Total votes polled stood at 18,555,905, representing full participation from promoter and public non-institutional holders. Key approvals included FY26 financials, director reappointment, and executive remuneration.
1mo agoBrooks Laboratories amends AGM resolution for ₹48.15 crore BSL guarantee
Brooks Laboratories issued an addendum on August 22, 2026, for its September 3 AGM. Resolution 4 amended to ratify ₹48.15 crore guarantee for joint venture BSL. Proposed FY27 related-party transaction limits total ₹35 crore plus guarantee. Aggregate exposure represents 96.99% of prior year consolidated turnover.
1mo agoBrooks Laboratories Ltd appoints Rajesh Mahajan as President
Brooks Laboratories Ltd appointed Mr. Rajesh Mahajan as President - Trading and Senior Management Personnel effective July 17, 2026. The company disclosed the appointment under Regulation 30 of the SEBI Listing Regulations. Mr. Mahajan brings over 20 years of experience in the pharmaceutical industry.
2mo agoBrooks Laboratories incorporates wholly owned subsidiary Abridge Speciality
Brooks Laboratories Limited has expanded its corporate structure by incorporating Abridge Speciality Limited on July 2, 2026. The wholly owned subsidiary, with an authorised capital of ₹1,00,000, will focus on the manufacturing and marketing of pharmaceuticals. The entity is yet to commence operations, and no regulatory approvals were required for its incorporation.
3mo agoBrooks Laboratories Ltd sells stake in Brooks Steriscience for ₹106.33 crore
Brooks Laboratories Ltd has approved the sale of 51,220 equity shares in Brooks Steriscience Limited for ₹20,760 per share, totaling approximately ₹106.33 crore. This transaction, which reduces the company's stake from 49.00% to 32.67%, was approved by the Board on June 19, 2026. The proceeds are earmarked for expansion, capacity enhancement, and general corporate purposes.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Brooks Laboratories is now worth
₹ 4,883.00
resulting in a loss of
₹ 5,117.00 (51.17%)
Note: Past profits do not guarantee future returns.
